Literature DB >> 7932516

Association analysis of a polymorphism of the angiotensinogen gene with essential hypertension in Japanese.

A Kamitani1, H Rakugi, J Higaki, Z Yi, H Mikami, T Miki, T Ogihara.   

Abstract

An association study of the polymorphism of the angiotensinogen gene, consisting of T-->C transition at nucleotide 704 in exon 2, with essential hypertension in the Japanese population was performed by restriction fragment length polymorphism (RFLP). The allele which contained the Tth 111-I restriction site in the presence of C transition was designated 'a' and the allele that lacked restriction site was designated 'A'. The frequency of aa genotype in our normotensive group was higher than the previously reported values in Caucasians. In spite of the high frequency of the aa genotype in Japanese, the aa genotype was significantly more frequent in 108 hypertensives than in 104 normotensive subjects compared with the two other genotypes (P = 0.009). These results suggested that this molecular variant of the angiotensinogen gene may be a preserved inherited predisposition for essential hypertension in various ethnic groups, including Caucasians and Japanese.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7932516

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  11 in total

1.  Young Scholars Award Lecture: Intratubular angiotensinogen in hypertension and kidney diseases.

Authors:  Hiroyuki Kobori; Yuri Ozawa; Yuki Suzaki; Minolfa C Prieto-Carrasquero; Akira Nishiyama; Tatsuya Shoji; Eric P Cohen; L Gabriel Navar
Journal:  Am J Hypertens       Date:  2006-05       Impact factor: 2.689

2.  Haplotypes of angiotensinogen in essential hypertension.

Authors:  X Jeunemaitre; I Inoue; C Williams; A Charru; J Tichet; M Powers; A M Sharma; A P Gimenez-Roqueplo; A Hata; P Corvol; J M Lalouel
Journal:  Am J Hum Genet       Date:  1997-06       Impact factor: 11.025

Review 3.  Angiotensinogen variants and human hypertension.

Authors:  X Jeunemaitre; A P Gimenez-Roqueplo; J Célérier; P Corvol
Journal:  Curr Hypertens Rep       Date:  1999 Feb-Mar       Impact factor: 5.369

4.  Association of the D allele of the angiotensin I converting enzyme polymorphism with malignant vascular injury.

Authors:  N J Mayer; A Forsyth; S Kantachuvesiri; J J Mullins; S Fleming
Journal:  Mol Pathol       Date:  2002-02

5.  Ten renin-angiotensin system-related gene polymorphisms in maximally treated Canadian Caucasian patients with heart failure.

Authors:  Marcin Zakrzewski-Jakubiak; Simon de Denus; Marie-Pierre Dubé; François Bélanger; Michel White; Jacques Turgeon
Journal:  Br J Clin Pharmacol       Date:  2008-02-12       Impact factor: 4.335

6.  Polymorphism of angiotensin-converting enzyme, angiotensinogen, and apolipoprotein E genes in Korean patients with cerebral infarction.

Authors:  Jae-Young Um; Kyung-Suk Moon; Kang-Min Lee; Kwang-Ho Cho; Yun Heo; Byung-Soon Moon; Hyung-Min Kim
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 3.444

Review 7.  [Role of the angiotensinogen gene for essential hypertension].

Authors:  E Brand; J Ringel; A M Sharma
Journal:  Herz       Date:  2000-02       Impact factor: 1.740

8.  Angiotensinogen M235T gene variants and its association with essential hypertension and plasma renin activity in Malaysian subjects: a case control study.

Authors:  Yee-How Say; King-Hwa Ling; Gnanasothie Duraisamy; Suzanne Isaac; Rozita Rosli
Journal:  BMC Cardiovasc Disord       Date:  2005-04-05       Impact factor: 2.298

9.  RAS gene polymorphisms, classical risk factors and the advent of coronary artery disease in the Portuguese population.

Authors:  Ana I Freitas; Isabel Mendonça; Maria Brión; Miguel M Sequeira; Roberto P Reis; Angel Carracedo; António Brehm
Journal:  BMC Cardiovasc Disord       Date:  2008-07-17       Impact factor: 2.298

10.  Intercellular adhesion molecule-1 K469E and angiotensinogen T207M polymorphisms in coronary slow flow.

Authors:  Emine Gazi; Ahmet Barutcu; Burak Altun; Ahmet Temiz; Adem Bekler; Mine Urfali; Fatma Silan; Yucel Colkesen; Ozturk Ozdemir
Journal:  Med Princ Pract       Date:  2014-06-14       Impact factor: 1.927

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.